Clinical Controversies in Multiple Myeloma

MMRF & Dana-Farber Cancer Center
Last Modified: July 13, 2007

Share article

Conference Dates: September 17, 2007
Conference Location: Best Western Inn at Longwood Medical

Sponsoring Group: MMRF & Dana-Farber Cancer Center

Conference Web Page URL:

Topics Covered: Frontline Therapy, Transplant, Relapsed/Refractory Disease, Supportive Care, Clinical Trials

Conference Objectives: Comprehensive overview of the latest information about multiple myeloma biological and clinical research.

Who Should Attend: Hematologists, Oncologists, Oncology Nurses, Internists

Conference Agenda:

  • 4:30PM - Registration
  • 5:00PM - Welcome and Introduction
  • 5:10PM - Frontline Therapy - Nikhil Munshi, MD
  • 5:35PM - Transplant - William Bensinger, MD
  • 6:00PM - Relapsed/Refractory Disease - Paul Richardson, MD
  • 6:25PM - Supportive Care - Sagar Lonial, MD
  • 6:50PM - Dinner
  • 7:10PM - Clinical Trials - Kenneth C. Anderson, MD

Registration Information: Register online or contact Sara Tyghter at 203.652.0219

Conference Fees: Free

Continuing Education: Yes

Miscellany: Free dinner will be provided

Related study shows that survival decreases with age in multiple myeloma patients

Mar 9, 2010 - The presence and number of focal lesions detected by whole-body magnetic resonance imaging strongly predicts the conversion of asymptomatic multiple myeloma to symptomatic disease, according to a study published online Feb. 22 in the Journal of Clinical Oncology. In a related study in the same issue, researchers report that survival after treatment for multiple myeloma decreases with age.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More